think it's worth much more - board valued it at 3.8m now but they might go to 19% over time - I have heard potential valuations for trillium in 2-3 yrs of US200-400m (when it lists) if that works out and PRR ends up with 19% thats A$50-100m for PRR (ok pie in the sky stuff but Trilium signed last year the biggest phase I deal for 2004 with Genentech - and they are huge). PRR's mkt cap is under $20m so you get the feel for how big this deal could be to them.
deal with trillium pharm, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $534.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3373 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 2712 | 1 |
View Market Depth
| Last trade - 15.39pm 03/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable